Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Fleshner

Showing results (211-220 of 266) with videos related to

Pageof 27
Sort By:
Cardio-Oncology (London, England)|March 29, 2025
Addressing cardiovascular risks with a goal to prevent cardiovascular complications in patients undergoing antihormonal therapy for prostate cancerNishant P Shah, Avinash Singh, Tia Higano, et al.
Radiology|May 25, 2021
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate CancerDominik Deniffel, Gerard M Healy, Xin Dong, et al.
The Journal of Urology|March 17, 2020
Reply by AuthorsHanan Goldberg, Ardalan E Ahmad, Thenappan Chandrasekar, et al.
The Journal of Urology|October 15, 2019
Comparison of Magnetic Resonance Imaging and Transrectal Ultrasound Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy Naïve Men: A Systematic Review and Meta-AnalysisHanan Goldberg, Ardalan E Ahmad, Thenappan Chandrasekar, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 25, 2021
The evolving role of germline genetic testing and management in prostate cancer: Report from the Princess Margaret Cancer Centre international retreatRoderick Clark, Miran Kenk, Kristen McAlpine, et al.
Urologic Oncology|July 9, 2025
Survival outcomes for men with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination deficiencies (HRD) treated with radium 223: Princess Margaret Cancer Centre (PMCC) experienceEsmail M Al-Ezzi, Osama Abdeljalil, Katherine Lajkosz, et al.
BJU International|December 1, 2025
Analysis of upper tract urothelial carcinoma in the Asian populationShane Qin, Kylie Lim, Jake Tempo, et al.
BJU International|April 25, 2025
Percentage of free to total PSA as a biomarker of survival in metastatic castration-resistant prostate cancerAndrew W Silagy, Dixon T S Woon, Louise Kostos, et al.
European Urology|July 12, 2014
Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian menAlexandre R Zlotta, Shin Egawa, Dmitry Pushkar, et al.
The Journal of Urology|February 19, 2020
A High Percent Free Prostate Specific Antigen in the Setting of Biochemical Recurrence after Radical Prostatectomy is Associated with Poorer Outcomes: A Validation Study Using Prospectively Collected Biobank SpecimensDixon T S Woon, Jaime O Herrera-Cáceres, Hanan Goldberg, et al.
Pageof 27

Showing results (211-220 of 266) with videos related to

Sort By:
Pageof 27
Cardio-Oncology (London, England)|March 29, 2025
Addressing cardiovascular risks with a goal to prevent cardiovascular complications in patients undergoing antihormonal therapy for prostate cancerNishant P Shah, Avinash Singh, Tia Higano, et al.
Radiology|May 25, 2021
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate CancerDominik Deniffel, Gerard M Healy, Xin Dong, et al.
The Journal of Urology|March 17, 2020
Reply by AuthorsHanan Goldberg, Ardalan E Ahmad, Thenappan Chandrasekar, et al.
The Journal of Urology|October 15, 2019
Comparison of Magnetic Resonance Imaging and Transrectal Ultrasound Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy Naïve Men: A Systematic Review and Meta-AnalysisHanan Goldberg, Ardalan E Ahmad, Thenappan Chandrasekar, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 25, 2021
The evolving role of germline genetic testing and management in prostate cancer: Report from the Princess Margaret Cancer Centre international retreatRoderick Clark, Miran Kenk, Kristen McAlpine, et al.
Urologic Oncology|July 9, 2025
Survival outcomes for men with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination deficiencies (HRD) treated with radium 223: Princess Margaret Cancer Centre (PMCC) experienceEsmail M Al-Ezzi, Osama Abdeljalil, Katherine Lajkosz, et al.
BJU International|December 1, 2025
Analysis of upper tract urothelial carcinoma in the Asian populationShane Qin, Kylie Lim, Jake Tempo, et al.
BJU International|April 25, 2025
Percentage of free to total PSA as a biomarker of survival in metastatic castration-resistant prostate cancerAndrew W Silagy, Dixon T S Woon, Louise Kostos, et al.
European Urology|July 12, 2014
Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian menAlexandre R Zlotta, Shin Egawa, Dmitry Pushkar, et al.
The Journal of Urology|February 19, 2020
A High Percent Free Prostate Specific Antigen in the Setting of Biochemical Recurrence after Radical Prostatectomy is Associated with Poorer Outcomes: A Validation Study Using Prospectively Collected Biobank SpecimensDixon T S Woon, Jaime O Herrera-Cáceres, Hanan Goldberg, et al.
Pageof 27